Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress induced phosphoprotein 1 pseudogene 3 (STIP1P3) is annotated as a pseudogene in the human genome[4]. Pseudogenes are genomic loci resembling protein-coding genes but incapacitated by disabling mutations—such as frameshifts, premature stop codons, or loss of crucial regulatory elements—such that they do not encode functional proteins[1][2]. STIP1P3 is related to the parental gene STIP1, but does not produce a functional protein product. Pseudogenes, while generally non-functional, can sometimes have regulatory effects at the RNA level, such as acting as competing endogenous RNAs or influencing expression through sequence similarity, but there is no evidence that STIP1P3 is involved in such regulation or in human disease or as a drug target[4].
Not applicable; no drugs act on this pseudogene[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress induced phosphoprotein 1 pseudogene 3 (STIP1P3).